Victory Capital Management
PNT

Victory Capital Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Victory Capital Management’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,395
Closed -$78K – 2801
2022
Q2 		$78K Sell
11,395
-77
-0.7% -$589 ﹤0.01% 2492
2022
Q1 		$98K Sell
11,472
-328
-3% -$2.08K ﹤0.01% 2516
2021
Q4 		$66K Buy
11,800
+1,256
+12% +$9.43K ﹤0.01% 2626
2021
Q3 		$81K Buy
+10,544
New +$96.2K ﹤0.01% 2642

Other funds holding PNT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Victory Capital Management's PNT Position: Q3 2022 in Review

Victory Capital Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q3 2022, closing a stake of 11,395 shares — an estimated $78K sold.

Victory Capital Management first reported a position in PNT in Q3 2021 and held it in 4 quarters. The position peaked at $98K in Q1 2022. 106 funds tracked by Wall St. Rank hold PNT as of Q3 2022.

  • Victory Capital Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 11,395 POINT Biopharma Global Inc. Common Stock shares in Q3 2022, an estimated $78K.
  • Victory Capital Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Victory Capital Management's POINT Biopharma Global Inc. Common Stock position peaked at $98K in Q1 2022.
  • 106 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.